The etiology of non-Hodgkin lymphoma (NHL) is poorly understood. Obesity is associated with inflammation, a cytokine milieu conducive to lymphocyte proliferation, and has been associated with NHL risk in some epidemiologic studies. To prospectively examine NHL risk in relation to adult and earlier life obesity, we documented 635 incident NHL diagnoses among 46,390 men in the Health Professionals Follow-up Study and 1254 diagnoses among 116,794 women in the Nurses' Health Study over 22-32 years of follow-up. Using multivariable Cox proportional hazards models we estimated cohort-specific incidence rate ratios (RRs) and 95% confidence intervals (CI) for risk of NHL and major histologic subtypes associated with cumulative average middle and young adult (ages 18-21) body mass index (BMI) and adolescent and childhood somatotype. NHL risk was modestly increased in men (but not women) with a cumulative average middle adult BMI ≥30 kg/m 2 (vs. 15-22.9 kg/m 2 ; RR: 1.28; 95% CI: 0.92, 1.77; Ptrend=0.05). In meta-analyses across cohorts, higher young adult BMI was associated with increased risk of all NHL (pooled RR per 5 kg/m 2 : 1.19; 95% CI: 1.05, 1.37), diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) (all P-trend≤0.02). Adolescent somatotype was also positively associated with all NHL, DLBCL, and FL in pooled analyses (all P-trend ≤0.03) while childhood somatotype was positively associated with NHL overall among women only (P-trend <0.01). These findings in two large prospective cohorts provide novel evidence that larger body size in childhood, adolescence, and young adulthood predicts increased risk of NHL, and particularly of DLBCL and FL.
Introduction
The etiology of non-Hodgkin lymphoma (NHL) is poorly understood, especially regarding modifiable risk factors that could inform prevention strategies. A significant but largely unexplained increase in NHL incidence rates has been observed for 30+ years, although rates have leveled off more recently (1, 2) . It is well documented that the prevalence of obesity has also risen sharply in the U.S. over recent decades (3) . Body weight and obesity are potentially modifiable risk factors that may contribute to lymphomagenesis by influencing inflammation or immune function (4) and have been associated with NHL risk in several epidemiologic studies (5) (6) (7) . In 2008, the International Lymphoma Epidemiology Consortium (InterLymph) published a large pooled analysis of 18 case-control studies with over 10,000 cases and concluded that there was no association between current adult body mass index (BMI) and risk of NHL, with the possible exception of an association for severe obesity (BMI ≥40 kg/m 2 ) with risk of diffuse large B-cell lymphoma (8) . In contrast, results from meta-analyses and some cohort studies suggest a weak to moderate positive association (5, 7) and more recent studies have found that the association may be stronger for weight/body size during early adulthood (9-13). We did not find current adult BMI to be a risk factor for NHL in a previous analysis with 14 years of follow-up in the Nurses' Health Study (NHS); however, this analysis was based on only 199 cases (14) . Prospective data on obesity and NHL risk are somewhat conflicting and limited first analyses after more than twice the follow-up and uses prospectively ascertained, validated anthropometric measures representing body size in adulthood and in earlier decades of life.
Methods

Study populations
The HPFS is an ongoing cohort study established in 1986 when 51,529 men who were Organization classification of lymphomas (15) . Specifically, diagnoses were made on the basis of morphology and immunophenotype information available in medical records and pathology reports. Immunophenotype information was not required for diagnoses of CLL/SLL or follicular lymphoma, which can be reliably diagnosed by morphology alone (15) . After exclusions, there were 1889 incident diagnoses of NHL (635 among men and 1254 among women) over the course of follow-up; of these, 531 were CLL/SLL (207 men; 324 women), 273 were diffuse large B-cell lymphoma (DLBCL) (87 men; 185 women), and 291 were follicular lymphoma (FL) (72 men; 219 women). The remaining cases included 308 patients with uncommon or unspecified B-cell histology, 88 patients with T-cell lymphoma, and 399 patients who were determined to have NHL on the basis of morphology alone but lacked adequate phenotyping to assign the tumor to the B-or T-cell lineage.
Exposure assessment
Men and women reported their current height and weight on the baseline questionnaire.
Men also reported young adult weight (i.e., at age 21) on the baseline questionnaire; women reported young adult weight (age 18) in 1980. Self-reported and technician-measured weight were highly correlated (r=0.97) in a subsample of HPFS and NHS participants (16) In 1988, study participants recalled their body size/fatness at ages 5, 10, and 20 years by selecting one of nine pictograms ("somatotypes") that best represented their body outline (1, most lean to 9, most overweight) at each age (18) . The validity of this exposure measure has been demonstrated: among older individuals in another study population, the correlations between recalled somatotype and BMI measured at approximately the same ages generally ranged from 0.53 to 0.75, although a lower correlation (0.36) was noted for males at age 5 (19) .
Waist and hip circumference were ascertained in 1987 (HPFS) and 1986 (NHS) and updated in 1996 (HPFS) and 2000 (NHS). Men and women whose hip or waist measurements were implausibly low (i.e., <29 inches for men; <20 inches for women) were excluded from relevant analyses. Waist and hip circumference measures were validated against technician measurements in a subset of study participants residing in the Boston area (16) .
Statistical analyses
Person-time of follow-up was calculated for each participant from the return date of the baseline questionnaire (i.e., 1986 for HPFS and 1976 NHS) to the date of lymphoma diagnosis, death, or the end of follow-up (January 2008, HPFS; June 2008, NHS), whichever occurred first.
For analyses of waist and hip circumference, follow-up began in 1986 for both cohorts. Men and women who reported cancer or who died were excluded from subsequent follow-up. Cox proportional hazards models, stratifying by 2-year questionnaire period and treating age in months as the time scale, were used to estimate incidence rate ratios (RRs) and 95 percent confidence intervals (CIs). To control for potential confounding, we fit multivariable models that included height (inches), race (white or non-white), smoking status (never, past, or current), and chosen because of evidence of an association with NHL in previous studies (14, 20, 21) .
Although there was no evidence of confounding by any of these variables in our study population (compared to age-adjusted models), we present results from fully adjusted models for completeness and ease of comparison to prior literature.
Cumulative average middle adult BMI was calculated as the mean of all available information on BMI from baseline up to the beginning of each 2-year follow-up cycle to represent "usual" middle adult BMI and was categorized as 15-22.9 We present results for each cohort separately as well as pooled results. We used a random effects meta-analysis approach to derive effect estimates for men and women combined and tested for heterogeneity by cohort/sex (22, 23) . We conducted analyses for NHL overall and also performed separate analyses for the most common NHL subtypes in these cohorts [i.e., CLL/SLL, DLBCL, and FL]. We used a contrast test, which followed an approximate χ 2 distribution, to test whether anthropometric measure associations with major NHL histologic subtypes differed significantly (22, 24) . Because of smaller sample sizes for NHL subtypes in men and women, we conducted the tests for heterogeneity by subtype in combined (i.e., pooled) analyses only. Individuals missing primary exposure variables were excluded from relevant analyses. Missing indicator categories were used to account for missing values for categorical covariates. All statistical tests were two-sided and P-values <0.05 were considered significant.
Results
Among men, the average age at baseline in 1986 was 54 years; among women, the average age at baseline in 1976 was 43 years. Men were less likely to have BMI <23 kg/m 2 (18%) compared to women (52%), but a similar proportion of men and women were obese (i.e., BMI ≥30 kg/m 2 ) (8% of both men and women). After excluding participants with BMI <15 kg/m 2 , less than 1% of men and <5% of women had BMI <18.5 kg/m 2 . As shown in Table 1 , women who were lean were slightly younger at baseline than those who were heavier. Among both men and women, young adult BMI, adolescent somatotype, and childhood somatotype were positively associated with adult BMI. Women were more likely than men to be current smokers at baseline (likely reflecting social norms in 1976 vs. 1986) and smoking was more prevalent among leaner women (Table 1) .
Based on multivariable models that adjusted for age, race, height, smoking history and physical activity, cumulative average middle adult BMI was weakly associated with increased risk of NHL overall among men but not among women (Table 2 ). In men, the RR for BMI ≥30 We next considered earlier life body size/fatness as assessed by adolescent and childhood somatotype. Larger adolescent somatotype was significantly associated with all NHL among both men and women (pooled P-trend <0.01) ( Table 3 ). For men, the RR for the highest category of adolescent somatotype compared to the lowest was 1.36 (95% CI: 0.98, 1.89); the corresponding RR for women was 1.40 (95% CI: 1.07, 1.83). In general, the strongest associations were noted for the DLBCL subtype, with both men and women of heavier/larger body types during adolescence experiencing almost twice the risk of DLBCL compared to leaner individuals (pooled P-trend = 0.02). There was also a significant association of adolescent somatotype with follicular lymphoma (pooled P-trend = 0.03), which was stronger among women (P-trend = 0.03). In contrast, there was no clear association with CLL/SLL. Again, there was no evidence of statistical heterogeneity by NHL subtype (Table 3) . These results were not materially changed upon adjustment for young adult BMI, cumulative average BMI, or both variables together. For example, regarding DLBCL, the RRs comparing the heaviest adolescent somatotype to the leanest were 1.64 (95% CI: 0.62, 4.37) and 1.90 (95% CI: 0.99, 3.62) for men and women, respectively, after adjusting for cumulative average middle adult BMI. The corresponding RRs were 1.70 (95% CI: 0.59, 4.91) and 1.62 (95% CI: 0.73, 3.57) after adjusting for young adult BMI. Further, similar positive associations of adolescent somatotype with all NHL and DLBCL were noted within strata of cumulative average BMI (data not shown).
Regarding childhood somatotype, a non-significant positive association with NHL was noted among men while larger childhood somatotype was significantly associated with risk of all NHL among women (P-trend <0.01) ( Table 3) .
We also examined adult waist circumference and waist-to-hip ratio as proxy measures of central adiposity. In general, results were similar to those from analyses of cumulative average Table) . As noted above, observed associations of cumulative average middle adult BMI and waist circumference in relation to all NHL were restricted to men (P-heterogeneity = 0.06 and 0.05, respectively); however, there was no evidence of statistically significant between-study heterogeneity (i.e., heterogeneity by sex) in analyses of young adult BMI or younger-age somatotype.
Finally, we confirmed our previous report of a significant positive association between height and NHL risk among women in the NHS (14) in this updated analysis. Specifically, the multivariable RR per 2-inch increment of height for NHL overall was 1.08 (95% CI: 1.03, 1.13; P-trend <0.01). For DLBCL, follicular lymphoma, and CLL/SLL, the corresponding RRs were Table) (P-heterogeneity <0.01).
Discussion
The present study extended our previous investigation of anthropometric risk factors for NHL through twice as many years of follow-up in the NHS and to men in the HPFS. Further, we incorporated novel data on young adult, adolescent and childhood body size. We observed statistically significant associations between BMI in young adulthood (i.e., ages 18 and 21) and risk of NHL, with somewhat stronger associations apparent for men and particularly for the 
DLBCL and FL subtypes of NHL. The findings for early life somatotype and NHL risk were consistent with results from our analysis of young adult BMI, with increased risks of NHL and particularly DLBCL and FL associated with larger body sizes during adolescence among both men and women, while associations with childhood somatotype were evident among women only. Usual middle adult BMI, as assessed by cumulative average BMI, was also weakly associated with NHL risk in men but not in women, whereas height predicted risk in women but not in men.
Although not all previous studies (9-11) have reported positive associations between BMI in adulthood and risk of NHL, the bulk of the more recent epidemiologic literature supports a weak positive association between obesity and NHL overall, with the most consistent evidence apparent for the DLBCL subtype (5, 8) . Several prior studies have evaluated central adiposity as measured by waist circumference and waist-to-hip ratio (9, 11, 25-27); most have found no association.
Fewer studies have evaluated measures of body size earlier in life (9-13, 27, 28).
Regarding BMI in young adulthood (i.e., age 18-21), the positive associations with NHL overall observed in the NHS and HPFS are consistent with the majority of these prior reports (9-13).
Together these results suggest that weight and body size during early adulthood may be more relevant for NHL etiology than body size later in life. An alternative explanation is that BMI between ages 18 and 21 better represents body fatness over a lifetime (10) ; however, we observed that associations between young adult BMI and NHL were stronger and more consistent than associations between a composite measure of usual middle adult BMI (i.e., cumulative average BMI) and NHL. We found the strongest associations for young adult BMI with the DLBCL and FL subtypes, particularly among women; however, subtype-specific Our findings of significantly increased NHL risk associated with larger body outlines in childhood and adolescence suggest that the role of obesity and body size in NHL may begin even earlier in life than ages 18-21. Again, this association was most apparent for DLBCL, but a positive association was also evident for adolescent body size and FL, which was stronger and statistically significant for women. Because body size in early and later life are strongly correlated, it is difficult to disentangle the effects on NHL risk. In these analyses, however, the positive association between adolescent somatotype and NHL persisted even after adjustment for young adult BMI and usual adult BMI, suggesting that early life body size plays a role in the development of NHL beyond its effect on later life body size. Further, the positive associations between adolescent body size and NHL risk were evident among individuals who were lean or heavy in adulthood. Statistical power to detect interaction in stratified analyses was limited, however. To our knowledge, only one prior study has evaluated a measure of body size in childhood or adolescence as a possible risk factor for NHL: Cerhan et al. (27) reported a positive association for "above average" relative weight at age 12 with risk of CLL and SLL, but no association for NHL overall, DLBCL, or FL. Positive associations with height in this and other studies (8, 9, 11, (28) (29) (30) (31) further support the hypothesis that early life influences are relevant to NHL etiology, as attained height reflects in part nutritional influences and circulating levels of growth factors and insulin-like growth factor-1 (IGF-1) early in life (32, 33) . While previous studies including men have reported positive associations between height and NHL (8, 29) , in our analyses, this association was observed only among women, consistent with genderrestricted findings reported by the Netherlands Cohort Study (28) . Although some differences in risk estimates were noted for men and women, there was no clear pattern of differences in associations and no statistical evidence of heterogeneity in effects by sex, with the exception of cumulative average middle adult BMI and waist circumference in relation to risk of all NHL. For example, associations between young adult BMI and NHL risk appeared stronger among men, while associations between childhood and adolescent somatotype and NHL risk appeared stronger among women. Observations of sexspecific associations may reflect differences between men and women in their recall of early life body size (19) or the distribution of unmeasured confounders or may be chance findings.
Various mechanisms may mediate the association between overweight/obesity and cancer (34) . In particular, pathways that involve B-cell proliferation or immunomodulation are biologically plausible with respect to NHL development. Obesity is known to be a proinflammatory state in which circulating levels of B-cell stimulatory cytokines, growth factors, and adipokines such as adiponectin and leptin are altered and immune function is impaired (34) (35) (36) (37) . Increased weight and height during childhood are also associated with IGF-1 measured concurrently (38) ; IGF-1, in turn, promotes B-cell proliferation and inhibits apoptosis (34, 39, 40) and could contribute to lymphomagenesis through these effects. In the NHS, however, early life body size was inversely correlated with IGF-1 levels measured later in adulthood (41) , suggesting that any mechanism potentially mediated by IGF-1 is complex. In addition, obesity is associated with increased levels of circulating insulin, insulin resistance, and chronic hyperinsulinemia, factors that favor cell growth and proliferation (34) . Recent epidemiologic evidence suggests that polymorphisms in the obesity-related genes leptin and leptin receptor, which are important for energy homeostasis and immune function, may be associated with NHL risk (42, 43) . Finally, excess body size could be a marker of diet or physical activity, factors (50) . It is unknown, however, whether these genetic and molecular markers mediate the association between obesity and NHL risk.
Some limitations to our analyses are worth noting. First, our assessments of weight and height rely on self-reported data. Similarly, assessment of childhood and adolescent body size and BMI at ages 18-21 was based on participants' recall. Although these measures have been validated and correlate well with actual measurements (12, 16, 19) , there is likely to be some 
measurement error. This error would be expected to be non-differential with respect to disease; therefore, any errors in exposure assessment would be likely to lead to attenuated effect estimates. Second, the majority of our study population is Caucasian. Although we adjusted for potential confounding by race and we are not aware of biological mechanisms that would operate differently to influence obesity-related NHL risk in Caucasians vs. non-Caucasians, our results may not be generalizeable to other racial/ethnic groups, for which the distribution of BMI may be different. Third, although we considered potential confounding by suspected NHL risk factors, confounding by unmeasured factors (e.g., by diet or infections), cannot be ruled out.
Despite these limitations, our study has several important strengths, including its prospective design, detailed information on covariates, and large sample size, allowing for separate analyses of common histologic subtypes of NHL, which may be etiologically distinct (46) . In addition, we had considerably longer follow-up (22-32 years) over which to assess risk compared to other prospective cohort studies (9-11, 25, 28) and we updated information on BMI every two years. Finally, to our knowledge, this is the first study to evaluate adolescent and childhood somatotype as risk factors for NHL. These analyses in two large prospective cohorts support the hypothesis that larger body size in childhood, adolescence, and young adulthood predicts an increased risk of NHL in both men and women, particularly for DLBCL and FL. 1 RR and CI from multivariable Cox proportional hazards regression models adjusted for age (as the time scale), height (continuous inches), smoking (never, past, current), physical activity (quintiles), race (white vs. non-white). 2 Test for heterogeneity by NHL subtype. 3 Trend test based on ordinal score. 4 Average of somatotype at ages 10 and 20 years based on 9-level pictogram. 5 Average of somatotype at ages 5 and 10 years based on 9-level pictogram.
